NCT00156884View on ClinicalTrials.gov

A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Hormone Refractory Prostate CancerBone Metastases
Interventions
DRUG

strontium-89

DRUG

cisplatin

Trial Locations (2)

T2N 4N2

Tom Baker Cancer Centre, Calgary

Unknown

BC Cancer Agency, Vancouver

Sponsors

Collaborators (1)

Amersham Health
All Listed Sponsors
collaborator

The Prostate Cancer Research Foundation of Canada

OTHER

collaborator

Amersham Health

INDUSTRY

lead

Alberta Health services

OTHER

NCT00156884 - A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer | Biotech Hunter | Biotech Hunter